DYDROBIG contains Dydrogesterone Tablets I.P. 10 mg, an orally active progestogen that is structurally and pharmacologically similar to natural progesterone. Each pack contains 10 x 1 x 10 tablets (100 tablets total), ensuring ease of dispensing and long-term therapy support. Indicated for luteal phase support, endometriosis, threatened abortion, recurrent pregnancy loss, and various menstrual cycle disorders. Manufactured by FEMiNA, DYDROBIG offers reliable efficacy with minimal androgenic and metabolic side effects.
You must be logged in to post a review.
Contains Spiramycin Tablets I.P. 3 M.I.U. (3 Million I.U.) , a macrolide antibiotic with potent anti-infective and antiparasitic activity
Provides high tissue penetration and prolonged post-antibiotic effect
Each pack contains 10 x 1 x 10 tablets (100 tablets total) , ideal for complete treatment courses
Indicated for toxoplasmosis (including in pregnancy), respiratory tract infections, oral infections, and STIs
Well-suited for prophylaxis and treatment of congenital toxoplasmosis
Generally well-tolerated with low risk of drug interactions
Manufactured by BAGRX PHARMACEUTICALS under the SPIRABAG™ brand
Contains Nitrofurantoin Sustained Release Tablets I.P. 100 mg, a urinary tract-specific antibacterial agent
Sustained release formulation ensures prolonged drug action and reduced dosing frequency
Each pack contains 10 x 10 tablets (100 tablets total) for extended treatment course and better compliance
Indicated for treatment and prevention of acute and recurrent uncomplicated urinary tract infections (UTIs)
Effective against susceptible gram-positive and gram-negative uropathogens including E. coli, Klebsiella, and Enterococcus
Achieves high urinary concentration with minimal systemic accumulation
Manufactured by FEMiNA under stringent quality standards
Reviews
There are no reviews yet.